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Abstract objective Although there is evidence that dengue virus is circulating in Tanzania, the country lacks
a dengue surveillance system. Consequently, the true estimate of dengue seroprevalence, as well as the
incidence in the population, the frequency and magnitude of outbreaks is unknown. This study
therefore sought to systematically review available dengue data from Tanzania.
methods The systematic review was conducted and reported using the PRISMA tool. Five
databases (PubMed, Embase, Web of Science, WHOLIS and Google Scholar) were searched for
articles using various keywords on the illness, data and geographical location. Identified articles were
assessed for inclusion based on predefined eligibility criteria. Data were extracted from included
articles, analysed and reported.
results Based on the 10 seroprevalence studies in defined populations with estimates of acute
confirmed infections that were included in the review, the estimated seroprevalence of past dengue
infection in Tanzania ranged from 50.6% in a health facility-based study to 11% in a population-
based study. Acute confirmed infections of dengue were estimated to be as high as 38.2% of
suspected cases. Only one study reported on an outbreak.
conclusions It is evident that dengue needs to become part of regular disease surveillance in
Tanzania. Control measures need to be instituted with a focus on building human resource capacity
and integrating dengue control measures in ongoing health programmes, for both preventive and
curative interventions. Systematic reviews are valuable in assessing health issues when surveillance
data are not available.
keywords dengue, surveillance, Tanzania
Introduction
Dengue is a vector-borne disease of major public health
concern due to its high morbidity and – to a lesser degree
– mortality, especially in low- and middle-income coun-
tries. It is estimated that there are nearly 400 million den-
gue infections globally each year [1]. With the global
extension of dengue [2] and the vectors being present in
most areas of the tropics and subtropics including East
Africa [3], control efforts seem to be failing. Clinically,
approximately one quarter of those infected exhibit
clinical signs and symptoms of dengue, including fever,
myalgias and rash, while one in ten will progress to more
severe forms of the disease [4]. Severe dengue (SD) is
defined by the presence of plasma leakage and shock, sev-
ere bleeding and organ failure. Case fatality rates can be
as high as 10–15%, although in countries with good clin-
ical management of dengue, they are consistently below
1% [5].
Yet, the global distribution and burden of dengue
remain highly uncertain [4]. Nowhere is this epidemiolog-
ical uncertainty more pronounced than in Africa, where
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• Illness (Dengue, DF (Dengue fever), Dengue Haemor-
rhagic (Hemorrhagic) Fever, DHF);
• Data (Surveillance, survey, incidence and prevalence
for one arm of the study and outbreak for the second
arm of the study); and
• Geographical location (Tanzania).
Contacts with principal investigators of relevant studies
identified and institutions in Tanzania, specifically the
MoH and WHO offices, were made for additional studies
and signposting sources of grey literature. DengueNet
[13] and ProMED-mail were identified as sources for grey
literature.
No restriction was placed on study design and year of
publication during the systematic literature search in
databases. Relevant studies identified were exported to
EndNote X7 (Philadelphia, PA, USA). Duplicates were
removed, and data were abstracted from eligible studies
into Microsoft Excel (Redmond, WA, USA). We also
manually searched reference lists of identified studies to
identify further relevant studies.
Eligibility was assessed using the following inclusion
criteria: (i) peer-reviewed articles on dengue infections
and outbreaks in Tanzania published in scientific jour-
nals; (ii) grey literature reporting on dengue infections
and outbreaks in Tanzania; and (iii) studies on serologi-
cal or laboratory investigations of dengue infections with
seroprevalence as primary outcome. Studies or reports on
the following were excluded: (i) dengue infections in trav-
ellers returning from Tanzania; (ii) entomological surveil-
lance data on dengue; (iii) characterisations of dengue
virus serotypes; (iv) non-human subjects; and (v) studies
conducted in East Africa excluding Tanzania.
Articles identified in the systematic literature search
were first screened for eligibility by title, and later by
abstract. Full texts of studies that fulfilled the eligibility
criteria at the title and abstract screening stage were fur-
ther screened for eligibility. Studies identified through
manual searches of reference lists were subjected to the
same screening procedure. The quality of included studies
was appraised using a tool designed by the Effective Pub-
lic Health Practice Project (EPHPP) for quantitative stud-
ies [14] and the Critical Appraisal Skills Programme
(CASP) Tool [15].
One example of such a search – in this case the second
arm of the study concerning outbreak reports – is the combi-
nation of Dengue (illness), outbreak (data) and Tanzania
(geographical location) on PubMed. This search generated
only 12 articles, with one relevant hit for outbreak reports
(reported later in the results section). Variations of the term
dengue did not generate any further hits.
Data on the following items were extracted and tabu-
lated from the included individual studies: references,
title, study design, objective, study population, exposure
the requisite infrastructure for diagnosis, surveillance and 
case reporting is lacking [5]. Despite the scarce data from 
the region, modelling frameworks suggest that Africa’s 
dengue burden may be similar to that of other high-trans-
mission areas, such as the Americas, with estimates as 
high as 16 million annual infections [6]. The distribution 
of DENV in Africa is also far from certain. All four 
DENV serotypes have been documented to circulate in 
Africa, although DENV-2 has been reported most fre-
quently [7].
The indirect evidence for the existence of endemic den-
gue transmission in Tanzania, however, is strong. There 
are high levels of precipitation and temperature suitability 
for dengue transmission, the Aedes aegypti mosquito, the 
primary vector of DENV, is endemic in much of Tanza-
nia, and there have been case reports of dengue infections 
in European and Asian travellers returning from Tanza-
nia [7, 8]. Other factors favouring the spread of endemic 
dengue transmission to Tanzania include an increasingly 
globalised economy and rapid urbanisation [9, 10].
There is also increasing direct evidence of endemic 
transmission in Tanzania. In 2014, the Tanzanian Min-
istry of Health (MoH) reported a dengue outbreak in 
Dar es Salaam to WHO [10, 11]. This outbreak spread 
to seven regions of mainland Tanzania and to regions on 
the island of Zanzibar. A total of 1018 cases were con-
firmed, of 2129 suspected cases. The response focused on 
surveillance, case management and vector control.
To date, no systematic review of the scientific literature 
has been undertaken to examine the evidence for endemic 
dengue transmission in Tanzania. This study aimed to 
systematically review all available data on dengue trans-
mission in Tanzania specifically: seroprevalence studies 
and outbreak reports, to provide recommendations for 
inclusion of dengue in regular disease surveillance and 
control programmes.
Methods
The systematic review was conducted and reported using 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) [12]. A systematic literature 
search was conducted independently by two researchers 
using five databases: Embase, Google Scholar, PubMed, 
Web of Science and WHOLIS. The last search was com-
pleted on 31 August 2016. The search terms were derived 
from three major categories, with one term of each cate-
gory to be combined for all possible combinations on all 
databases:
study conducted retrospectively provided a PI seropreva-
lence estimate of 11% [16].
Studies reporting on confirmed acute infections
A total of five studies [18–20, 22, 23] reported on this
outcome; one study conducted in the southern part of
mainland Tanzania reported 38.2% CAI [18]. The four
remaining studies conducted in the northern and southern
part of the mainland in the island of Zanzibar revealed
no cases of CAI. The studies were mostly derived from
health centre-based patient cohorts, with different sizes.
Study reporting on dengue outbreaks
One study [26] reported on dengue outbreaks in 62 locali-
ties of Tanzania, with a higher percentage of acute cases on
the plateau than in the lowlands – 94% and 12%, respec-
tively. The number of acute cases in two of three plateau
regions was significantly lower in adult males than children
(x2 = 11.71, and 6.66, P < 0.01). In the lowlands, acute
cases were identified only in adult males and females.
Dengue and age distribution
All studies reporting on the association between dengue
infections and age confirmed an increase in the risk of
past infections with increasing age [18–21]. One study
reported a significant increase in the odds of dengue
infection with every 5-year increase in age [21].
Dengue and its relation to seasonality and place of
residence
One study found a strong association between CAI of den-
gue and the dry season with an odds ratio of 5.03 (95%CI:
1.68–15.01, P = 0.004) [18], while another reported no
association with seasonality 1.3 (95%CI: 0.73–2.2,
P = 0.381) [19]. This study further reported that past den-
gue infections were common in the rural community
(OR = 1.8, P = 0.027) [19], while another study observed
frequent infections in the urban population (adjusted
OR = 4.09, 95%CI: 2.72–6.17, P < 0.001) [21].
Dengue and other febrile diseases, including co-infections
Misdiagnosis of dengue bymedical personnel and co-infec-
tions with other febrile illnesses were reported by two stud-
ies [18, 19]. As many as 52% and 28%of people with CAI
actually had urinary tract infection (UTI) andmalaria,
respectively, as their main diagnosis [18]. In another study,
45% of people with PAI hadmalaria as provisional
of interest (dengue infections and outbreaks) and out-
comes (presumptive acute, past and confirmed acute 
DENV infections for seroprevalence and epidemiological 
factors associated with dengue infections).
From the included studies, we conducted a descriptive 
analysis of the extracted data, with outcomes focusing on 
seroprevalence and outbreaks. Seroprevalence data were 
extracted using the percentage of presumptive acute and 
past infections, as suggested by the presence of anti-DENV 
IgG (past) or IgM (acute). With the difficulties of interpre-
tation of diagnostic tests in the context of dengue [5], these 
are classified as past infections (PIs), presumptive acute 
infection (PAI) and confirmed acute infections (CAI). CAI 
are presented using the percentage of CAI of suspected 
dengue cases, determined by viral RNA (RT-PCR) [5]. 
Analysis of outcomes was based on categorisation of study 
characteristics such as study design and demographics of 
study population and geographical location.
Results
For the first arm of the systematic review, seroprevalence 
studies, nine articles [16–24] meeting the eligibility criteria 
were included. A report of dengue cases from Tanzania was 
identified at ProMED-mail website [25]. A total of 72 arti-
cles were initially identified as potentially relevant based on 
title, of 147 152 search results from five databases. After 
the removal of 60 duplicates, a manual search of references 
and contacting study authors yielded another six relevant 
studies. Further screening via abstract and full-text reading 
resulted in exclusion of nine articles.
For the second arm of the study, outbreak reports, 
16 articles were potentially relevant based on title of 
31 131 search results from five databases. A total of 
10 duplicates were removed, and upon abstract and 
title screening, only one study [26] met the eligibility 
criteria.
Details of reasons for exclusion at each screening stage 
are provided in Figures 1 and 2, and characteristics of 
included studies are presented in Table 1.
Studies reporting on seroprevalence
Four studies [18–20, 22] reported on both PAI and PI 
and two on PI only [16, 21]. The percentage of PAI and 
PI ranged from 0–20.9% and 6.6–50.6%, respectively. 
The highest seroprevalence of PAI was 20.9% in a study 
with only children as study participants [18], and absence 
of PAI was recorded in a study with both children and 
adults as participants [22]. A low PI seroprevalence of 
6.6% was reported in children [18], with a higher sero-
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weak. Recently, there have been reports of a dengue out-
break in Dar es Salaam [10]. However, a search for liter-
ature revealed no publication on this outbreak. This
further highlights that even in an epidemic situation,
reporting and scientific documentation of dengue out-
breaks are non-existent in Tanzania, and confirming the
assertion by Amarasinghe and Were that most outbreaks
in Africa are under-reported [9, 17].
Dengue and age distribution
All studies reported an increase in past dengue infections
among adults with one study showing an increase in
infection with every 5 years [21]. Guo [30] states that
this association suggests endemicity of dengue in a popu-
lation, as the disease pattern shows an increase in past
infections in adults coupled with the wide spread of com-
petent vectors (Aedes aegypti) [3].
Dengue and seasonality
There was a discrepancy in data on whether seasonality is
associated with the frequency of dengue infections, with
inconclusive results. Whereas one study found no associa-
tion with seasonality [19], another reported that dengue
infections were more likely to occur during the dry season
[18]. A search for a possible explanation of this phe-
nomenon revealed that transmission occurs year-round in
endemic countries, although cases are frequent in the rainy
season as demonstrated in a study conducted in China and
Thailand [31, 32]. Occurrence in the dry season may be
linked to storage of water due to erratic supply.
Dengue and place of residence
Findings from one of the studies suggest that past infections
were common in rural areas [19] and another reported a
higher seroprevalence in urban areas [21]. It is possible that
movement of people between communities and presence of
breeding sites may account for this observation. Gubler [6]
confirms that rapid urbanisation, globalisation and absence
of control measures to eliminate vectors and their breeding
sites are elements that facilitate the spread of dengue infec-
tions. There is no reason to assume that dengue has a dif-
ferent residential distribution, as reported in countries with
a functional surveillance system.
Issues arising from dengue data in Tanzania
Although dengue is often misdiagnosed as malaria [33, 34],
results from this review suggest that patients with dengue
diagnosis [19]. Furthermore, 8.5% of people with dengue 
infections had co-infections with malaria and 1% had co-
infections with chikungunya [18]. In another study, concur-
rent infection with chikungunya was 13.4%; with malaria, 
7.3%; and with HIV, 8.8% [19].
Discussion
This discussion follows categories derived thematically 
from included studies and their respective results during 
the analysis: (i) Dengue and seroprevalence studies, (ii) 
Dengue and CAI, (iii) Dengue outbreak, (iv) Dengue and 
age distribution (v), Dengue, seasonality and place of res-
idence and (vi) Dengue and other febrile illnesses. Dengue 
data from Tanzania are based on studies conducted in 
some parts of Tanzania, as there is no specific dengue 
surveillance system in place. However, this is a result of 
the study, and no attempt was made to generalise the 
findings, or to extrapolate to the population. Data from 
this systematic review are presented in following the prin-
ciple high quality vs. moderate and low quality, as deter-
mined by the quality analysis.
Dengue and seroprevalence studies
As expected, the seroprevalence of antidengue IgG, repre-
sentative of past infection, was higher than IgM and was 
more common in adults than children [18, 21]. Peyerl-Hoff-
man’s [27] study confirms this observation which is proba-
bly due to the increasing risk of exposure over time. The 
highest estimate of PAI was observed in children [18]. This 
finding is similar to results of studies conducted in Vietnam 
[28], and dengue is one of the common acute childhood ill-
nesses in endemic countries [29]. A large population-based 
study reported an estimate of 11% for seroprevalence; this 
might be the best estimate for the true prevalence of dengue 
in the Tanzanian population encountered in this systematic 
review [16].
Dengue and CAI
All CAI were in children between the ages of 2 and
13 years [18]. A similar pattern of increased PAI was 
seen in a study conducted among Vietnamese children, 
whereas in another study conducted in South Laos, past 
infections were rather common [27, 28].
Dengue outbreak
As only one study – of moderate quality – reported on 
this outcome [26], evidence from our systematic review 
with regard to dengue outbreaks in Tanzania is very
Conclusion and recommendations
This systematic review, based on data from seroprevalence
studies and outbreak reports, suggests ongoing dengue
activity in Tanzania, often up to high levels. The need for
integrating dengue into the national surveillance system,
including concepts for confirmatory laboratory diagnosis, is
clear. Also, as no dengue surveillance exists currently, it has
to be established whether healthcare personnel is aware of
dengue as a reason for febrile illness, and perhaps capacity-
building in terms of dengue diagnosis, identification and
appropriate case management especially for severe dengue
cases should be recommended. This would help to treat
cases of severe dengue and related mortality, and avoid
cases of misdiagnosis. Future outbreaks of dengue could
have more severe cases and capacity needs to be built to mit-
igate their impact on health services.
It is further recommended to consider integration of
dengue as a target disease in ongoing vector control pro-
grammes, particularly in the light of other Aedes-trans-
mitted diseases – however also considering efficacy,
effectiveness and cost-effectiveness of Aedes control.
Further studies investigating the epidemiology of den-
gue and how best to integrate dengue control efforts into
ongoing disease control programmes are needed. System-
atic reviews prove to be valuable in assessing health
issues when no surveillance data are available.
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